The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.

The trial enrolled chronic myeloid leukaemia patients irrespective of their T315I mutation status. Credit: Nemes Laszlo/Shutterstock. Enliven Therapeutics has reported the latest positive results from ...

This week on Pipeline Moves, we kick off by looking at Pfizer’s topline data from a Phase II trial of ponsegromab on cancer cachexia. Meanwhile, IMPACT Therapeutics senaparib has seen its phase ...

The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.

ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...

FluMist is a live-attenuated influenza vaccine. Credit: PeopleImages.com – Yuri A via Shutterstock. The US Food and Drug ...

An NHS paediatrician sent a WhatsApp message offering children and parents £1,500 to take part in Moderna’s Phase III ...

AbbVie has revealed positive data from a post-hoc analysis of Phase III trials of RINVOQ in treating atopic dermatitis (AD).

Eli Lilly’s EBGLYSS received FDA approval for atopic dermatitis treatment earlier this month. Credit: Katherine Welles / Shutterstock. Eli Lilly and Company has announced new long-term data from the ...

BMS and 2seventy bio decided to halt the KarMMa-9 study, which is said to be influenced by the evolving treatment landscape for NDMM. Credit: Bristol-Myers Squibb Company. Bristol Myers Squibb (BMS) ...